Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases

Imagem de Miniatura
Arquivos
art_SAAD_Immunogenicity_and_safety_of_the_2009_nonadjuvanted_influenza_2011.PDF (119.41 KB)
Citações na Scopus
80
Tipo de produção
article
Data de publicação
2011
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
B M J PUBLISHING GROUP
Autores
Citação
ANNALS OF THE RHEUMATIC DISEASES, v.70, n.6, p.1068-1073, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Despite the WHO recommendation that the 2010-2011 trivalent seasonal flu vaccine must contain A/California/7/2009/H1N1-like virus there is no consistent data regarding its immunogenicity and safety in a large autoimmune rheumatic disease (ARD) population. Methods 1668 ARD patients (systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), ankylosing spondylitis (AS), systemic sclerosis, psoriatic arthritis (PsA), Behcet's disease (BD), mixed connective tissue disease, primary antiphospholipid syndrome (PAPS), dermatomyositis (DM), primary Sjogren's syndrome, Takayasu's arteritis, polymyositis and Granulomatosis with polyangiitis (Wegener's) (GPA)) and 234 healthy controls were vaccinated with a non-adjuvanted influenza A/California/7/2009(H1N1) virus-like strain flu. Subjects were evaluated before vaccination and 21 days post-vaccination. The percentage of seroprotection, seroconversion and the factor increase in geometric mean titre (GMT) were calculated. Results After immunisation, seroprotection rates (68.5% vs 82.9% p < 0.0001), seroconversion rates (63.4% vs 76.9%, p < 0.001) and the factor increase in GMT (8.9 vs 13.2 p < 0.0001) were significantly lower in ARD than controls. Analysis of specific diseases revealed that seroprotection significantly reduced in SLE (p < 0.0001), RA (p < 0.0001), PsA (p=0.0006), AS (p=0.04), BD (p=0.04) and DM (p=0.04) patients than controls. The seroconversion rates in SLE (p < 0.0001), RA (p < 0.0001) and PsA (p=0.0006) patients and the increase in GMTs in SLE (p < 0.0001), RA (p < 0.0001) and PsA (p < 0.0001) patients were also reduced compared with controls. Moderate and severe side effects were not reported. Conclusions The novel recognition of a diverse vaccine immunogenicity profile in distinct ARDs supports the notion that a booster dose may be recommended for diseases with suboptimal immune responses. This large study also settles the issue of vaccine safety. (ClinicalTrials.gov #NCT01151644)
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/22650
Referências
  1. Abu-Shakra M, 2007, AUTOIMMUN REV, V6, P543, DOI 10.1016/j.autrev.2006.12.004
  2. Agmon-Levin N, 2009, ISR MED ASSOC J, V11, P183
  3. Salemi S, 2010, CLIN IMMUNOL, V134, P113, DOI 10.1016/j.clim.2009.09.014
  4. Tebas P, 2010, AIDS, V24, P2187, DOI 10.1097/QAD.0b013e32833c6d5c
  5. Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1
  6. Scharpe J, 2008, AM J TRANSPLANT, V8, P332, DOI 10.1111/j.1600-6143.2007.02066.x
  7. Agmon-Levin N, 2009, NAT REV RHEUMATOL, V5, P648, DOI 10.1038/nrrheum.2009.196
  8. Fiore Anthony E., 2010, Morbidity and Mortality Weekly Report, V59, P1
  9. Issa NC, 2011, BIOL BLOOD MARROW TR, V17, P434, DOI 10.1016/j.bbmt.2010.10.002
  10. Setti M, 2009, VACCINE, V27, P3367, DOI 10.1016/j.vaccine.2009.01.078
  11. Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
  12. Elkayam O, 2010, SEMIN ARTHRITIS RHEU, V39, P442, DOI 10.1016/j.semarthrit.2008.12.002
  13. Crowe BA, 2010, VACCINE, V29, P166, DOI 10.1016/j.vaccine.2010.10.065
  14. Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x
  15. BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606
  16. van Assen S, 2011, ANN RHEUM DIS, V70, P414, DOI 10.1136/ard.2010.137216
  17. Cook IF, 2008, VACCINE, V26, P3551, DOI 10.1016/j.vaccine.2008.04.054
  18. van Assen S, 2010, ARTHRITIS RHEUM-US, V62, P75, DOI 10.1002/art.25033
  19. Wiesik-Szewczyk E, 2010, CLIN RHEUMATOL, V29, P605, DOI 10.1007/s10067-010-1373-y
  20. Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972
  21. LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101
  22. Vitali C, 1996, ANN RHEUM DIS, V55, P116, DOI 10.1136/ard.55.2.116
  23. Gelinck LBS, 2008, ANN RHEUM DIS, V67, P713, DOI 10.1136/ard.2007.077552
  24. Holvast A, 2009, RHEUMATOLOGY, V48, P1294, DOI 10.1093/rheumatology/kep200
  25. Bingham CO, 2010, ARTHRITIS RHEUM-US, V62, P64, DOI 10.1002/art.25034
  26. Shoenfeld Y, 2011, J AUTOIMMUN, V36, P4, DOI 10.1016/j.jaut.2010.07.003
  27. Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453
  28. AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129
  29. ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302
  30. Bickel M, 2010, AIDS, V24, pF31, DOI 10.1097/QAD.0b013e3283398da1
  31. BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706
  32. Brammer L., 2010, Morbidity and Mortality Weekly Report, V59, P38
  33. Centers for Disease Control and Prevention, QUEST ANSW VACC SEL
  34. Conti F, 2008, AUTOIMMUN REV, V8, P124, DOI 10.1016/j.autrev.2008.07.007
  35. Criteria for diagnosis of Behcet's disease, 1990, LANCET, V335, P1078
  36. Holvast A, 2010, ANN RHEUM DIS, V69, P924, DOI 10.1136/ard.2009.112813
  37. Holvast A, 2009, ARTHRITIS RHEUM, V60, P2438, DOI 10.1002/art.24679
  38. Kasukawa R, 1987, MIXED CONNECTIVE TIS, P41
  39. Kendal AP, 1982, CONCEPTS PROCEDURES
  40. Lu CC, 2011, VACCINE, V29, P444, DOI 10.1016/j.vaccine.2010.10.081
  41. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581
  42. Scharpe J, 2009, AM J KIDNEY DIS, V54, P77, DOI 10.1053/j.ajkd.2008.11.032
  43. VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361
  44. Waddington CS, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14460-01

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/17
Artigos e Materiais de Revistas Científicas - LIM/36
Artigos e Materiais de Revistas Científicas - LIM/48